HROW
Harrow Health Inc
30.50$
-0.3%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 38.5% | 44.6% | 42.5% | 45.5% | 41.8% | 48.8% | 46.6% | 44.9% | 48.9% | 53.0% | 54.0% | 55.0% | |
| 22.9% | 23.8% | 23.2% | 23.1% | 20.7% | 12.1% | 18.3% | 15.4% | 20.5% | 18.3% | 22.6% | 20.1% | |
| 25.8% | 26.5% | 25.7% | 23.1% | 20.7% | 12.1% | 18.3% | 16.2% | 20.5% | 18.3% | 22.6% | 20.1% | |
| 6.5% | 11.7% | 9.9% | 17.0% | 15.4% | 30.0% | 21.2% | 22.8% | 21.4% | 27.8% | 24.1% | 28.4% | |
| 3.1% | 3.5% | 3.7% | 3.1% | 2.9% | 2.8% | 2.9% | 3.3% | 3.5% | 3.4% | 3.9% | 4.1% | |
| 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | |
| 56.9% | 51.3% | 53.9% | 51.2% | 54.4% | 48.0% | 50.1% | 51.6% | 47.9% | 43.9% | 43.4% | 42.4% | |
| 73.6% | 77.5% | 79.6% | 81.0% | 83.6% | 82.2% | 84.6% | 85.7% | 87.1% | 87.0% | 93.2% | 96.4% | |
| 6.7% | 15.8% | 14.1% | 17.5% | 27.0% | 23.5% | 51.3% | 72.1% | 18.0% | 24.1% | 21.8% | 24.5% | |
| 0.3% | 0.3% | 0.3% | 0.3% | 0.1% | 0.1% | 29.9% | 53.4% | 0.2% | 0.2% | 0.2% | 0.2% | |
| 2.1% | 6.9% | 4.3% | 6.6% | 7.2% | 10.0% | 10.2% | 6.8% | 5.2% | 8.9% | 6.2% | 8.2% | |
| 63.7% | 58.8% | 62.3% | 60.3% | 52.9% | 56.4% | 30.9% | 11.2% | 66.9% | 60.9% | 69.6% | 70.1% | |
| 26.5% | 22.6% | 20.5% | 19.1% | 16.5% | 17.9% | 15.5% | 14.4% | 12.9% | 13.1% | 6.8% | 3.6% | |
| -43.6% | -43.0% | -49.9% | -50.2% | -45.0% | -38.9% | -46.5% | -47.6% | -44.9% | -39.2% | -43.9% | -48.3% | |
| 12.0% | 11.3% | 12.0% | 11.6% | 10.2% | 9.2% | 9.8% | 11.3% | 10.7% | 9.2% | 8.9% | 9.0% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.